Nashville, TN, United States of America

Jijun Hao


Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Nashville, TN (US) (2014 - 2015)
  • Biamond Bar, CA (US) (2019)

Company Filing History:


Years Active: 2014-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jijun Hao: Innovator in Hedgehog Signaling and Stem Cell Differentiation

Introduction

Jijun Hao is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the fields of biochemistry and regenerative medicine. With a total of 3 patents, his work focuses on innovative compounds and methods that have the potential to impact various medical applications.

Latest Patents

Jijun Hao's latest patents include groundbreaking research on compounds and methods for the inhibition of hedgehog signaling and phosphodiesterase. These compounds and compositions are designed to inhibit hedgehog signaling and/or phosphodiesterase-4 activity. Additionally, he has developed methods useful for directing stem cell differentiation. This subject matter relates to compounds and methods for selectively differentiating stem cells and screening for compounds that enhance the terminal differentiation of committed cardiac progenitor cells.

Career Highlights

Jijun Hao is affiliated with Vanderbilt University, where he conducts his research and development. His work has garnered attention for its potential applications in treating various diseases and advancing stem cell therapies. His innovative approach to biochemistry has positioned him as a key figure in his field.

Collaborations

Jijun Hao collaborates with notable colleagues, including Charles C Hong and Corey R Hopkins. These partnerships enhance the research efforts and contribute to the advancement of their shared goals in scientific discovery.

Conclusion

Jijun Hao's contributions to the fields of hedgehog signaling and stem cell differentiation exemplify the impact of innovative research in medicine. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…